In recent years, tremendous efforts have been made in the medical treatment of metastatic renal cell carcinoma (mRCC), with immune-oncological combinations standing as the current standard of care in the first-line setting of mRCC. In these podcasts, expert authors discuss the current treatment landscape for these new therapies and discuss what should be taken into account when choosing the most appropriate treatment for their patients so as to balance outcomes, adverse events and quality of life.
